Research Topic · Peer-Reviewed

Angiosarcoma

Angiosarcoma is a rare and aggressive form of cancer that affects the cells lining the walls of blood vessels and lymphatic vessels. It is a subtype of sarcoma, a group of cancers that arise from soft tissue or bone. Angiosarcoma can occur in any part of the body, but it is most commonly found in the skin, breast, l…

Curated from this journal's research 📚 4 peer-reviewed articles cited Cited 1× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed June 2026

Overview

Angiosarcoma is a rare and aggressive form of cancer that affects the cells lining the walls of blood vessels and lymphatic vessels. It is a subtype of sarcoma, a group of cancers that arise from soft tissue or bone. Angiosarcoma can occur in any part of the body, but it is most commonly found in the skin, breast, liver, and spleen. The cause of angiosarcoma is not well understood, but it is believed to be linked to exposure to certain chemicals such as vinyl chloride, arsenic, and thorium dioxide. It can also develop in people who have had radiation therapy or who have chronic lymphedema (swelling due to a disruption of the lymphatic system). Symptoms of angiosarcoma can vary depending on its location, but commonly include pain, swelling, and redness. In some cases, it may present as a bruise-like lesion. Diagnosis involves a combination of imaging studies and a biopsy of the suspected area. Treatment for angiosarcoma usually involves surgery to remove the affected tissue, followed by radiation therapy and chemotherapy to kill any remaining cancer cells. The prognosis for angiosarcoma is poor, with a high risk of recurrence and spread to other parts of the body. In summary, angiosarcoma is a rare and aggressive cancer that affects the blood vessels and lymphatic vessels. It can occur in various parts of the body and is linked to certain environmental and medical factors. Early detection and aggressive treatment are crucial for improving a patient's prognosis.

Research published in this journal

4 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2022

Primary Breast Sarcoma

Exact topic Clinical Case Reports and Images Cited by 1 doi:10.14302/issn.2641-5518.jcci-22-4323

How this research is being cited

The 4 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

A sample of recent works citing this journal's research on Angiosarcoma, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.